CN1839918A - Clover formulation - Google Patents
Clover formulation Download PDFInfo
- Publication number
- CN1839918A CN1839918A CN 200610032656 CN200610032656A CN1839918A CN 1839918 A CN1839918 A CN 1839918A CN 200610032656 CN200610032656 CN 200610032656 CN 200610032656 A CN200610032656 A CN 200610032656A CN 1839918 A CN1839918 A CN 1839918A
- Authority
- CN
- China
- Prior art keywords
- clover
- tablet
- extract
- extraction
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Disclosed is an extract of daghestan sweetclover with coumarin constituent, wherein the preparing process includes one or more selected from vapor distillation method, base dissolving acid settling method, solvent extraction method and supercritical extraction method. The extract can be made into preparation in the forms of tablets, dispersible tablets, orally disintegrating tablets, capsules, hard capsules, soft capsules, granules, suppository, drop pills, sprays, aerosols or micro capsules.
Description
Affiliated technical field:
The invention belongs to pharmaceutical, mainly is the soft tissue injury swelling that treatment causes because of wound, surgical operation etc.Symptom is as soft tissue injury swelling that a variety of causes such as bruise, fracture, chronic strain, burn and scald, plastic operation, varicosis, phlebitis, lymphatic return obstacle cause.And all kinds hemorrhoid such as treatment each phase internal hemorrhoid, mixed hemorrhoid, external hemorrhoid cause hemorrhage, deviate from, pain, swelling etc.Can also be used for swelling behind the hemorrhoids operation, treatment of pain.Be a kind of clover formulation specifically.
Background technology:
At present, also do not find to have similar products and preparation method thereof on the market.
Summary of the invention:
The objective of the invention is to: the object of the present invention is to provide a kind of bioavailability height, scattered, absorb new pharmaceutical formulation complete, evident in efficacy.
The technical solution used in the present invention is: the extraction system Coumarins composition of melilotus of the present invention, extracting method are to be extracted by following one or more technologies to make with extra care and finish: steam distillation, alkali extraction and acid precipitation method, solvent extraction method, supercritical extraction; The preparation medicine that the present invention is prepared into by this extract, said medicine are tablet, ordinary tablet, dispersible tablet, oral cavity disintegration tablet, capsule, hard capsule, soft capsule, granule, suppository, drop pill, spray, aerosol, microcapsule etc.
The preparation that this extract is made is used for:
The soft tissue injury swelling that 1 treatment causes because of wound, surgical operation etc.Symptom is as soft tissue injury swelling that a variety of causes such as bruise, fracture, chronic strain, burn and scald, plastic operation, varicosis, phlebitis, lymphatic return obstacle cause.
That all kinds hemorrhoid such as 2 treatment each phase internal hemorrhoid, mixed hemorrhoids, external hemorrhoid cause is hemorrhage, deviate from, pain, swelling etc.Can also be used for swelling behind the hemorrhoids operation, treatment of pain.
Embodiment:
The extraction system Coumarins composition of melilotus of the present invention, extracting method are to be extracted by following one or more technologies to make with extra care and finish: steam distillation, alkali extraction and acid precipitation method, solvent extraction method, supercritical extraction; The preparation medicine that the present invention is prepared into by this extract, said medicine are tablet, ordinary tablet, dispersible tablet, oral cavity disintegration tablet, capsule, hard capsule, soft capsule, granule, suppository, drop pill, spray, aerosol, microcapsule etc.
The preparation that this extract is made is used for:
The soft tissue injury swelling that 1 treatment causes because of wound, surgical operation etc.Symptom is as soft tissue injury swelling that a variety of causes such as bruise, fracture, chronic strain, burn and scald, plastic operation, varicosis, phlebitis, lymphatic return obstacle cause.
That all kinds hemorrhoid such as 2 treatment each phase internal hemorrhoid, mixed hemorrhoids, external hemorrhoid cause is hemorrhage, deviate from, pain, swelling etc.Can also be used for swelling behind the hemorrhoids operation, treatment of pain.
Claims (3)
1, a kind of clover formulation is characterized in that: the extraction system Coumarins composition of melilotus of the present invention.
2, clover formulation according to claim 1 is characterized in that: extracting method is to be extracted by following one or more technologies to make with extra care and finish: steam distillation, alkali extraction and acid precipitation method, solvent extraction method, supercritical extraction.
3, clover formulation according to claim 1, it is characterized in that: the preparation medicine that the present invention is prepared into by extract, said medicine are tablet, ordinary tablet, dispersible tablet, oral cavity disintegration tablet, capsule, hard capsule, soft capsule, granule, suppository, drop pill, spray, aerosol, microcapsule etc.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610032656 CN1839918A (en) | 2006-01-05 | 2006-01-05 | Clover formulation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610032656 CN1839918A (en) | 2006-01-05 | 2006-01-05 | Clover formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1839918A true CN1839918A (en) | 2006-10-04 |
Family
ID=37029221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200610032656 Pending CN1839918A (en) | 2006-01-05 | 2006-01-05 | Clover formulation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1839918A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111548336A (en) * | 2020-05-28 | 2020-08-18 | 广西壮族自治区林业科学研究院 | Method for separating coumarin from cinnamon oil heavy fraction |
| CN111808060A (en) * | 2020-06-28 | 2020-10-23 | 湖南杰萃生物技术有限公司 | Method for extracting total coumarin from rhodiola rosea |
-
2006
- 2006-01-05 CN CN 200610032656 patent/CN1839918A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111548336A (en) * | 2020-05-28 | 2020-08-18 | 广西壮族自治区林业科学研究院 | Method for separating coumarin from cinnamon oil heavy fraction |
| CN111808060A (en) * | 2020-06-28 | 2020-10-23 | 湖南杰萃生物技术有限公司 | Method for extracting total coumarin from rhodiola rosea |
| CN111808060B (en) * | 2020-06-28 | 2023-11-14 | 湖南杰萃生物技术有限公司 | Method for extracting total coumarin from rhodiola rosea |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20180271924A1 (en) | Compound and method for reducing inflammation, pain, allergy, flu and cold symptoms | |
| KR101444698B1 (en) | Composition for improvement, treatment and prevention of gastrointestinal motility disorders | |
| CN102813635A (en) | Pharmaceutical composition | |
| CN101926801A (en) | Medicinal composition | |
| CN1839918A (en) | Clover formulation | |
| CN101327289B (en) | Novel uses of day lily and day lily total flavones | |
| CN1969997A (en) | Antivirus compound formulation, preparation process, quality control method and use thereof | |
| CN103120652B (en) | Phloroglucin orally disintegrating tablet and preparation method thereof | |
| CN1970000A (en) | Antivirus Chinese medicinal formulation, preparation process, quality control method and application thereof | |
| CN1969871A (en) | Antivirus compound formulation, preparation process, quality control method and use thereof | |
| CN1907329A (en) | Children's rheum tablet and its preparation | |
| CN100551360C (en) | Isatis root effervescence tablet and preparation method thereof | |
| CN101121662A (en) | Chlorogenic acid ester derivative, preparation method and application thereof in pharmaceutical preparation | |
| CN101371870A (en) | Method for preparing sweet clover extract and medicinal value thereof | |
| CN112843104B (en) | Application of Elaeagnus luvifolia extract in preparation of medicine for treating stomach related diseases | |
| CN102048810B (en) | Dracocephalum moldavica general flavone orally disintegrating tablet and preparation method thereof | |
| CN1559447A (en) | Extracte of Aspongopus chinensis Dallas and Extraction method therefor medicinal use and preparn. thereof | |
| CN100551361C (en) | Influenza defervesce effervescent tablet and preparation method | |
| CN1927337A (en) | Preparation process of medicine for treating cough and asthma | |
| CN110302166A (en) | A kind of swap buffers tablet and preparation method thereof | |
| CN104398543A (en) | Application of folium ginkgo composition to preparation of medicine for preventing or treating glaucoma | |
| CN112843123B (en) | Application of Fujian cyclobalanopsis glauca extract in preparation of medicine for treating stomach related diseases | |
| KR101326241B1 (en) | Pharmaceutical Composition for improving anti pain Comprising Lonicerae Flos Extracts | |
| CN1907274A (en) | Pharmaceutical preparation such as hemsleyadine dispersable tablet et al. and preparation method thereof | |
| CN1969870A (en) | Antivirus compound formulation, preparation process, quality control method and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Gao Chengfu Document name: Notification before expiration of term |
|
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Gao Chengfu Document name: Notification that Application Deemed to be Withdrawn |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |